Viracta Therapeutics (VIRX)
(Delayed Data from NSDQ)
$0.84 USD
+0.04 (4.48%)
Updated May 15, 2024 03:58 PM ET
After-Market: $0.81 -0.03 (-3.57%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.28 |
EPS Last Quarter | -0.23 |
Last EPS Surprise | 34.29% |
ABR | 1.25 |
Earnings ESP
|
43.53% |
---|---|
Current Year | -1.06 |
Next Year | -0.99 |
EPS (TTM) | -1.23 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.28 | -0.25 | -1.06 | -0.99 |
# of Estimates | 3 | 3 | 3 | 2 |
Most Recent Consensus | NA | -0.23 | -1.05 | -1.05 |
High Estimate | -0.16 | -0.15 | -0.72 | -0.93 |
Low Estimate | -0.35 | -0.36 | -1.42 | -1.05 |
Year ago EPS | -0.32 | -0.33 | -1.32 | -1.06 |
Year over Year Growth Est. | 12.50% | 24.24% | 19.70% | 6.92% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 1 | 1 |
Up Last 30 Days | 0 | 1 | 2 | 2 |
Up Last 60 Days | 0 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.28 | -0.25 | -1.06 | -0.99 |
7 Days Ago | -0.28 | -0.25 | -1.10 | -1.01 |
30 Days Ago | -0.35 | -0.30 | -1.28 | -1.27 |
60 Days Ago | -0.35 | -0.30 | -1.28 | -1.27 |
90 Days Ago | -0.30 | -0.28 | -1.20 | -1.24 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.16 | -0.19 | -0.89 | -0.99 |
Zacks Consensus Estimate | -0.28 | -0.25 | -1.06 | -0.99 |
Earnings ESP | 43.53% | 22.97% | 16.77% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.23 | -0.35 | -0.33 | -0.32 | NA |
Estimate | -0.35 | -0.30 | -0.33 | -0.30 | NA |
Difference | 0.12 | -0.05 | 0.00 | -0.02 | 0.01 |
Surprise | 34.29% | -16.67% | 0.00% | -6.67% | 2.74% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more